journal article·2014-11

Poly(2-ethyl-(2-pyrrolidone) methacrylate) and hyaluronic acid–based hydrogels for the engineering of a cartilage-like tissue using bovine articular chondrocytes

Joana Magalhães, Aileen Crawford, Paul V Hatton, Francisco J Blanco, Julio San Roman

Publisher page

Abstract

Poly(2-ethyl-(2-pyrrolidone)methacrylate)–hyaluronic acid hydrogels based on the free radical polymerization of 2-ethyl-(2-pyrrolidone)methacrylate combined with hyaluronic acid, using N,N′-methylenebisacrylamide or triethylene glycol dimethacrylate, as cross-linking agents, were considered for tissue engineering applications. Bovine articular chondrocytes were seeded onto the poly(2-ethyl-(2-pyrrolidone)methacrylate)–hyaluronic acid hydrogels, under orbital agitation, for a total of 40 days. The engineered cell-constructs were characterized according to cell proliferation, morphology and distribution as well as the biochemical composition of the tissue formed. The chondrocytes were found to be attached and presented a typical spherical morphology. Cells were able to proliferate and synthesize a hyaline-like matrix rich in glycosaminoglycans and collagen type II which were mainly located on the superficial area. Increased content of individual components poly(2-ethyl-(2-pyrrolidone)methacrylate) and hyaluronic acid, in triethylene glycol dimethacrylate–cross-linked networks led to enhanced cell distribution and total glycosaminoglycans content, supporting their potential application for the repair of cartilaginous tissues.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Knee injuries and reconstruction techniques · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain

Grupo de Bioingeniería Tisular y Terapia Celular (GBTTC-CHUAC), Servicio de Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), A Coruña, Spain

Centre for Biomaterials and Tissue Engineering, School of Clinical Dentistry, Sheffield, UK

Department of Biomaterials, Institute of Polymer Science and Technology, CSIC, Madrid, Spain

References (54)

Show source-provided references
1. 10.2174/13894500978848840410.2174/138945009788488404 ↗
2. 10.1002/art.2317610.1002/art.23176 ↗
3. 10.7326/0003-4819-133-8-200010170-0001610.7326/0003-4819-133-8-200010170-00016 ↗
4. 10.1097/01.bor.0000151406.64393.0010.1097/01.bor.0000151406.64393.00 ↗
5. 10.1002/art.2058910.1002/art.20589 ↗
6. 10.1038/nrrheum.2009.8810.1038/nrrheum.2009.88 ↗
7. 10.1056/NEJM19941006331140110.1056/NEJM199410063311401 ↗
8. 10.3928/0147-7447-19980701-0410.3928/0147-7447-19980701-04 ↗
9. 10.1177/036354650832841410.1177/0363546508328414 ↗
10. 10.1177/036354650935114310.1177/0363546509351143 ↗
11. 10.1186/ar219510.1186/ar2195 ↗
12. 10.1038/ncprheum014110.1038/ncprheum0141 ↗
13. 10.5435/00124635-199407000-0000210.5435/00124635-199407000-00002 ↗
14. 10.2106/00004623-198264030-0002210.2106/00004623-198264030-00022 ↗
15. 10.1016/S0142-9612(99)00213-610.1016/S0142-9612(99)00213-6 ↗
16. 10.1016/j.knee.2006.02.01210.1016/j.knee.2006.02.012 ↗
17. 10.1186/ar280010.1186/ar2800 ↗
18. 10.1186/ar263810.1186/ar2638 ↗
19. Podskubka A · Acta Chir Orthop Traumatol Cech · 2006 · 73 · 25110.55095/achot2006/036 ↗
20. 10.1055/s-2006-93344510.1055/s-2006-933445 ↗
21. 10.1177/036354650935070410.1177/0363546509350704 ↗
22. 10.1302/0301-620X.87B5.1590510.1302/0301-620X.87B5.15905 ↗
23. 10.1186/ar218010.1186/ar2180 ↗
24. Khan WS · J Stem Cells · 2012 · 7 · 97
25. 10.1016/j.actbio.2013.03.00510.1016/j.actbio.2013.03.005 ↗
26. 10.1177/088391151142014910.1177/0883911511420149 ↗
27. 10.1163/156856204175302510.1163/1568562041753025 ↗
28. 10.1002/adma.20100396310.1002/adma.201003963 ↗
29. Balazs EA · J Rheumatol Suppl · 1993 · 39 · 3
30. 10.1016/S0142-9612(02)00194-110.1016/S0142-9612(02)00194-1 ↗
31. 10.1177/088391150404160810.1177/0883911504041608 ↗
32. 10.1177/088391150809947210.1177/0883911508099472 ↗
33. 10.1177/088391151142070010.1177/0883911511420700 ↗
34. 10.1177/088391150910226610.1177/0883911509102266 ↗
35. 10.1002/jbm.a.3431210.1002/jbm.a.34312 ↗
36. 10.1177/088391150935786310.1177/0883911509357863 ↗
37. Crawford A · 2004
38. Kafienah W · 2004
39. 10.1016/0304-4165(86)90306-510.1016/0304-4165(86)90306-5 ↗
40. 10.1016/j.actbio.2009.05.00410.1016/j.actbio.2009.05.004 ↗
41. 10.1177/088391151349461810.1177/0883911513494618 ↗
42. 10.1023/B:ABME.0000007786.37957.6510.1023/B:ABME.0000007786.37957.65 ↗
43. 10.1007/s10856-006-0692-710.1007/s10856-006-0692-7 ↗
44. Pelttari K · Swiss Med Wkly · 2009 · 139 · 602
45. 10.1106/3EH5-2R73-RC4V-Y9L710.1106/3EH5-2R73-RC4V-Y9L7 ↗
46. 10.1089/ten.tec.2010.046710.1089/ten.tec.2010.0467 ↗
47. 10.1016/j.actbio.2009.09.00610.1016/j.actbio.2009.09.006 ↗
48. 10.1177/088391151349462010.1177/0883911513494620 ↗
49. 10.1002/jbm.121710.1002/jbm.1217 ↗
50. 10.1016/j.eurpolymj.2008.09.01010.1016/j.eurpolymj.2008.09.010 ↗
51. 10.1016/j.ijpharm.2008.11.00810.1016/j.ijpharm.2008.11.008 ↗
52. 10.1089/ten.tea.2007.032710.1089/ten.tea.2007.0327 ↗
53. 10.1016/j.biomaterials.2007.08.00710.1016/j.biomaterials.2007.08.007 ↗
54. 10.1089/ten.teb.2011.007710.1089/ten.teb.2011.0077 ↗